Camidanlumab Tesirine
ADC Therapeutics
['hodgkin', 'pivotal', 'lymphoma']
#icymi: (#client) reported results from the pivotal phase 2 clinical trial of its cd25-targeted #antibodydrugconjugate for patients with relapsed or refractory hodgkin #lymphoma at #eha2022. read more: 
6 Degrees is a results-oriented, full-service public relations firm that serves clients across the health care spectrum. Led by principal, @MediaMinder.